{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:08:27Z","timestamp":1779314907580,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":952,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1002\/rth2.12357","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T17:18:28Z","timestamp":1588094308000},"page":"524-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Fibrinolytic therapy for refractory COVID\u201019 acute respiratory distress syndrome: Scientific rationale and review"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-8155","authenticated-orcid":false,"given":"Christopher D.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Apgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Talmor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Sauaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah R.","family":"Liptzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia A.","family":"Veress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-3251","authenticated-orcid":false,"given":"Michael B.","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1002\/rth2.12357_bb0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2020.4031","article-title":"Critical care utilization for the COVID\u201019 outbreak in Lombardy, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"issue":"18","key":"10.1002\/rth2.12357_bb0015","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1002\/rth2.12357_bb0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS\u2010CoV\u20102 pneumonia in Wuhan, China: a single\u2010centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1002\/rth2.12357_bb0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"16","key":"10.1002\/rth2.12357_bb0030","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically Ill patients with COVID\u201019 in Washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"issue":"21","key":"10.1002\/rth2.12357_bb0035","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair allocation of scarce medical resources in the time of Covid\u201019","volume":"382","author":"Emanuel","year":"2020","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1002\/rth2.12357_bb0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2020.4344","article-title":"Coronavirus disease 2019 (COVID\u201019) in Italy","volume":"323","author":"Livingston","year":"2020","journal-title":"JAMA"},{"issue":"18","key":"10.1002\/rth2.12357_bb0045","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1002\/rth2.12357_bb0050","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1002\/rth2.12357_bb0055","first-page":"252","article-title":"Vascular endothelial injuries and changes of blood coagulation and fibrinolysis indexes in patients with acute respiratory distress syndrome","volume":"19","author":"He","year":"2004","journal-title":"Chin Med Sci J"},{"issue":"5","key":"10.1002\/rth2.12357_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0028-1092878","article-title":"The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury","volume":"34","author":"Hofstra","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1002\/rth2.12357_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-5223(19)33719-5","article-title":"Pulmonary microthrombi. Caveat for successful modified Fontan operation","volume":"106","author":"Olson","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4 Suppl","key":"10.1002\/rth2.12357_bb0070","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","volume":"31","author":"Idell","year":"2003","journal-title":"Crit Care Med"},{"issue":"4 Pt 1","key":"10.1002\/rth2.12357_bb0075","first-page":"L240","article-title":"Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome","volume":"261","author":"Idell","year":"1991","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1002\/rth2.12357_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0039-1701016","article-title":"Temporal changes in fibrinolysis following injury","volume":"46","author":"Moore","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1002\/rth2.12357_bb0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TA.0000000000000341","article-title":"Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy","volume":"77","author":"Moore","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"10.1002\/rth2.12357_bb0090","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/TA.0000000000001718","article-title":"Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator","volume":"83","author":"Moore","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"4","key":"10.1002\/rth2.12357_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1002\/rth2.12357_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0040-1702202","article-title":"The complexity of trauma\u2010induced coagulopathy","volume":"46","author":"Moore","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12357_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID\u201019 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1002\/rth2.12357_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1164\/ajrccm.153.1.8542111","article-title":"Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome","volume":"153","author":"Fuchs\u2010Buder","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/rth2.12357_bb0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijid.2020.02.043","article-title":"2019\u2010novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation","volume":"93","author":"Albarello","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1002\/rth2.12357_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(76)90135-2","article-title":"Intravascular coagulation associated with the adult respiratory distress syndrome","volume":"61","author":"Bone","year":"1976","journal-title":"Am J Med"},{"issue":"4","key":"10.1002\/rth2.12357_bb0125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2006-948288","article-title":"Pathophysiology of acute lung injury and the acute respiratory distress syndrome","volume":"27","author":"Ware","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"18","key":"10.1002\/rth2.12357_bb0130","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/rth2.12357_bb0135","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID\u201019) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1002\/rth2.12357_bb0140","unstructured":"Luo W, Yu H\u2010J, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID\u201019) Preprint. 2020:1\u201318. https:\/\/doi.org\/10.13140\/RG.2.2.22934.29762"},{"key":"10.1002\/rth2.12357_bb0145","article-title":"Pulmonary and cardiac pathology in Covid\u201019: the first autopsy series from New Orleans","author":"Fox","year":"2020","journal-title":"MedRxiv"},{"issue":"4","key":"10.1002\/rth2.12357_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2006-948290","article-title":"The role of the coagulation cascade in the continuum of sepsis and acute lung injury and acute respiratory distress syndrome","volume":"27","author":"Bastarache","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"2 Pt 1","key":"10.1002\/rth2.12357_bb0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome","volume":"161","author":"G\u00fcnther","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1002\/rth2.12357_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2302\/kjm.54.142","article-title":"Coagulation and fibrinolysis in human acute lung injury\u2013new therapeutic targets?","volume":"54","author":"Ware","year":"2005","journal-title":"Keio J Med"},{"issue":"7","key":"10.1002\/rth2.12357_bb0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/thx.2006.063305","article-title":"The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor","volume":"62","author":"Bastarache","year":"2007","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/rth2.12357_bb0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0038-1656009","article-title":"Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells","volume":"77","author":"Grau","year":"1997","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1002\/rth2.12357_bb0175","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1592\/phco.27.6.860","article-title":"Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome","volume":"27","author":"MacLaren","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1002\/rth2.12357_bb0180","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS\u2010CoV\u20102 infection","author":"Han","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/rth2.12357_bb0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1002\/rth2.12357_bb0190","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12357_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14860","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID\u201019: a comment","author":"Barrett","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1002\/rth2.12357_bb0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1002\/rth2.12357_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059368","article-title":"Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers","volume":"8","author":"Ostrowski","year":"2013","journal-title":"PLoS ONE"},{"issue":"10234","key":"10.1002\/rth2.12357_bb0210","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID\u201019","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/rth2.12357_bb0215","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"issue":"4 Suppl","key":"10.1002\/rth2.12357_bb0220","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1097\/01.CCM.0000057912.71499.A5","article-title":"Anticoagulant therapy in acute lung injury","volume":"31","author":"Laterre","year":"2003","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1002\/rth2.12357_bb0225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.CCM.0000201882.23917.B8","article-title":"Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia\u2013a review","volume":"34","author":"Schultz","year":"2006","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1002\/rth2.12357_bb0230","doi-asserted-by":"crossref","first-page":"L307","DOI":"10.1152\/ajplung.00157.2006","article-title":"Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury","volume":"291","author":"Ware","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"10.1002\/rth2.12357_bb0235","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00246-011-0058-x","article-title":"Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator","volume":"32","author":"Heath","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1002\/rth2.12357_bb0240","first-page":"43","article-title":"Fibrinolytic agents: a new approach to the treatment of adult respiratory distress syndrome","volume":"11","author":"Hardaway","year":"1994","journal-title":"Adv Ther"},{"issue":"12","key":"10.1002\/rth2.12357_bb0245","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/00003246-199012000-00021","article-title":"Prevention of adult respiratory distress syndrome with plasminogen activator in pigs","volume":"18","author":"Hardaway","year":"1990","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1002\/rth2.12357_bb0250","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0891-5849(98)00047-1","article-title":"Tissue plasminogen activator (tPA) inhibits interleukin\u20101 induced acute lung leak","volume":"25","author":"Stringer","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1002\/rth2.12357_bb0255","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3389\/fimmu.2018.01898","article-title":"Meta\u2010analysis of preclinical studies of fibrinolytic therapy for acute lung injury","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1002\/rth2.12357_bb0260","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/toxsci\/kfu225","article-title":"Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation","volume":"143","author":"Veress","year":"2015","journal-title":"Toxicol Sci"},{"issue":"4","key":"10.1002\/rth2.12357_bb0265","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/000313480106700417","article-title":"Treatment of severe acute respiratory distress syndrome: a final report on a phase I study","volume":"67","author":"Hardaway","year":"2001","journal-title":"Am Surg"},{"issue":"4","key":"10.1002\/rth2.12357_bb0270","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.4.e67","article-title":"Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature","volume":"109","author":"Costello","year":"2002","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/rth2.12357_bb0275","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00246-008-9312-2","article-title":"Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature","volume":"30","author":"Do","year":"2009","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"10.1002\/rth2.12357_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.PCC.0000149320.06424.1D","article-title":"Long\u2010term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient","volume":"6","author":"Wakeham","year":"2005","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"10.1002\/rth2.12357_bb0285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1824-7288-40-18","article-title":"Management of plastic bronchitis with nebulized tissue plasminogen activator: another brick in the wall","volume":"40","author":"Colaneri","year":"2014","journal-title":"Ital J Pediatr"},{"issue":"9","key":"10.1002\/rth2.12357_bb0290","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/phar.1290","article-title":"Pharmacotherapy challenges of fontan\u2010associated plastic bronchitis: a rare pediatric disease","volume":"33","author":"Brooks","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1002\/rth2.12357_bb0295","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1513\/AnnalsATS.201209-080OC","article-title":"Immunophenotyping and protein profiling of Fontan\u2010associated plastic bronchitis airway casts","volume":"10","author":"Racz","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1002\/rth2.12357_bb0300","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1345\/aph.1R690","article-title":"Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis","volume":"47","author":"Lubcke","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1002\/rth2.12357_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1089253213475879","article-title":"Perioperative management of shock in two fontan patients with plastic bronchitis","volume":"17","author":"Singhal","year":"2013","journal-title":"Semin Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1002\/rth2.12357_bb0310","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2011-2883","article-title":"Management of plastic bronchitis with topical tissue\u2010type plasminogen activator","volume":"130","author":"Gibb","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/rth2.12357_bb0315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/toxsci\/kfx151","article-title":"Editor's highlight: Pulmonary vascular thrombosis in rats exposed to inhaled sulfur mustard","volume":"159","author":"McGraw","year":"2017","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1002\/rth2.12357_bb0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/nyas.13130","article-title":"Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy","volume":"1378","author":"White","year":"2016","journal-title":"Ann NY Acad Sci"},{"issue":"10","key":"10.1002\/rth2.12357_bb0325","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"Covid\u201019 does not lead to a \"typical\" Acute Respiratory Distress Syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1002\/rth2.12357_bb0330","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1002\/rth2.12357_bb0335","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1002\/rth2.12357_bb0340","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all\u2010cause mortality, major bleeding, and intracranial hemorrhage: a meta\u2010analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/rth2.12357_bb0345","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate\u2010risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1002\/rth2.12357_bb0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5483\/BMBRep.2011.44.1.34","article-title":"A novel variant of t\u2010PA resistant to plasminogen activator inhibitor\u20101; expression in CHO cells based on in silico experiments","volume":"44","author":"Davami","year":"2011","journal-title":"BMB Rep"},{"issue":"5","key":"10.1002\/rth2.12357_bb0355","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID\u201019","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12357_bb0360","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID\u201019","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.1002\/rth2.12357_bb0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS\u2010CoV\u20102 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"6483","key":"10.1002\/rth2.12357_bb0370","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo\u2010EM structure of the 2019\u2010nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"6485","key":"10.1002\/rth2.12357_bb0375","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS\u2010CoV\u20102 by full\u2010length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1002\/rth2.12357_bb0380","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-5521(00)00125-3","article-title":"Negative selectivity and the evolution of protease cascades: the specificity of plasmin for peptide and protein substrates","volume":"7","author":"Hervio","year":"2000","journal-title":"Chem Biol"},{"key":"10.1002\/rth2.12357_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID\u201019 associated acute respiratory distress syndrome (ARDS): a case series","author":"Wang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12357_bb0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcm7050111","article-title":"Practice trends of fibrinogen monitoring in thrombolysis","volume":"7","author":"Kaufman","year":"2018","journal-title":"J Clin Med"},{"issue":"7","key":"10.1002\/rth2.12357_bb0395","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1002\/rth2.12357_bb0400","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/SHK.0000000000000161","article-title":"Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients","volume":"41","author":"Cardenas","year":"2014","journal-title":"Shock"},{"key":"10.1002\/rth2.12357_bb0405","unstructured":"Whitton C, Rigsby P, Longstaff C. A Proposed 1st WHO International Standard for the Measurement of Tissue Plasminogen Activator (tPA) Antigen in Plasma 94\/730. https:\/\/wwwwhoint\/biologicals\/expert_committee\/BS%202068%20tissue%20plasminogenpdf Accessed on May 15, 2020; 2007."},{"key":"10.1002\/rth2.12357_bb0410","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2020.04.011","article-title":"Pulmonary embolism in patients with COVID\u201019: time to change the paradigm of computed tomography","volume":"190","author":"Rotzinger","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.1002\/rth2.12357_bb0415","first-page":"115","article-title":"Pharmacokinetics of the recombinant thrombolytic agents. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene","volume":"11","author":"Cohen","year":"1999","journal-title":"Therapy"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12357","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12357","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:21:27Z","timestamp":1762863687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2475037922020210"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12357","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrinolytic therapy for refractory COVID\u201019 acute respiratory distress syndrome: Scientific rationale and review","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}